Ghent University Hospital
Ghent, 9000, Belgium
Location status: Recruiting
NCT Number: NCT06780514
The goal of this clinical trial is to have a beter insight in the exercise tolerance in girls with Turner Syndrome aged 8-18 years . The main question it aims to answer is:
Is there a difference in VO2 max comparing Turner syndrome girls with standard values? How do cardiovascular parameters change during exercise (heart rate, bloodpressure, ...)
Participants will perform a cyclo-ergometry in a standardised way.
Interested in participating?
Request Info8 year–18 year
Female
Interventional
Not applicable
Ghent, 9000, Belgium
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
To our knowledge, this is the first study to perform CPET's in Turner Girls aged <18 years
Other names: CPET, cyclo-ergometry
Time frame: Whitin a week after the CPET
VO2 max is the maximum volume (V) of oxygen (O2) your body can process during exercise
Time frame: Whitin a week after the CPET
Time frame: Whitin a week after the CPET
Interested in participating?
Request InfoUniversity Hospital, Ghent
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02417740
Cardiovascular Abnormalities, Cardiovascular Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT06507007
Cardiovascular Abnormalities, Cardiovascular Diseases
Herning, Denmark
View Trial DetailsNCT07221851
Bone Diseases, Bone Diseases, Developmental
Palo Alto, California, United States
View Trial DetailsNCT06834594
Adnexal Diseases, Cardiovascular Abnormalities
Kansas City, Missouri, United States
View Trial Details